• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nrx Pharmaceuticals Inc (NQ: NRXP )

    2.180 -0.400 (-15.50%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 611,417
    Open 2.060
    Bid (Size) 2.080 (7)
    Ask (Size) 2.250 (50)
    Prev. Close 2.580
    Today's Range 2.020 - 2.300
    52wk Range 0.2210 - 6.000
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    +336.87%
    +336.87%
    1 Month
    +315.24%
    +315.24%
    3 Month
    +489.19%
    +489.19%
    6 Month
    +613.58%
    +613.58%
    1 Year
    +238.04%
    +238.04%

    More News

    Read More
    Gold Down Over 2%; 3M Profit Beats Expectations
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    (NRXP) - Analyzing NRX Pharmaceuticals's Short Interest
    Via Benzinga
    Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
    Via Benzinga
    InvestorNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M
    Via Investor Brand Network
    Exposures Product Safety
    Nasdaq Down 0.5%; Lithium Americas Shares Slide
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Is Bio-Path (BPTH) Stock Up 89% Today?
    Via InvestorPlace
    Why Is AGBA Group (AGBA) Stock Up 149% Today?
    Via InvestorPlace
    Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    New Data on Infection Avoidance and Development of pH Neutral Ketamine, for Intravenous and Subcutaneous Use: NRx Pharmaceuticals (Nasdaq: NRXP)
    Via Get News
    Exposures Product Safety
    Successful Development of pH Neutral Ketamine, Potentially Enabling Both Intravenous and Subcutaneous Use; Trials Progressing for Suicide Drug Treatment After Strong Q4 Results: NRXP
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    NRX’s (NASDAQ: NRXP) NMDA Modification Therapy And Its Multiple Applications From Mental Health To Chronic Pain
    Via News Direct
    NRXP Stock Earnings: NRX Pharmaceuticals Beats EPS for Q4 2023
    Via InvestorPlace
    Earnings Scheduled For March 28, 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.